Pancreatic Cancer Research

ResearcherEuropean Institute of OncologyActive in the last 2 years

Giuseppe Riccardo Diaferia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4022-8483; OpenAlex author ID A5071438907. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. Pancreatic Cancer Frequently Infiltrates the TRIANGLE Compartment: A Surgical Option to Prevent Local Recurrence. Co-author DOI 10.1097/as9.0000000000000672↗
  2. A framework to mine laser microdissection-based omics data and uncover regulators of pancreatic cancer heterogeneity. First author DOI 10.1093/gigascience/giaf101↗
  3. Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2024.02.017↗
  4. Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer. Co-author DOI 10.1126/sciadv.adk5386↗
  5. Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells. Co-author DOI 10.1136/gutjnl-2021-325811↗
  6. Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A. Co-author DOI 10.1136/gutjnl-2020-322814↗
  7. Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants. First author DOI 10.15252/embj.2020107206↗
  8. Pancreatic Cancer Cells Require the Transcription Factor MYRF to Maintain ER Homeostasis. Co-author DOI 10.1016/j.devcel.2020.09.011↗
  9. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner. Co-author DOI 10.15252/embj.2019102161↗
  10. Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer. Co-author DOI 10.15252/embj.201592404↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gioacchino Natoli · 9 shared papers, 2016–2025 · strength 1.63
  2. Pierluigi Di Chiaro · 4 shared papers, 2023–2025 · strength 0.86
  3. Alessandro Zerbi · 5 shared papers, 2016–2024 · strength 0.61
  4. Marta Milan · 4 shared papers, 2019–2023 · strength 0.59
  5. Iros Barozzi · 2 shared papers, 2024–2025 · strength 0.53
  6. Gabriele Alfarano · 3 shared papers, 2019–2023 · strength 0.37
  7. Vera Oliveira · 1 shared paper, 2026 · strength 0.24
  8. Gil Gonçalves · 1 shared paper, 2026 · strength 0.24
  9. Filipe C. Borges · 1 shared paper, 2026 · strength 0.24
  10. Mireia Castillo-Martín · 1 shared paper, 2026 · strength 0.24
  11. Ingmar Florin Rompen · 1 shared paper, 2026 · strength 0.24
  12. Peter J. Bailey · 1 shared paper, 2026 · strength 0.24
  13. Markus Wolfgang Büchler · 1 shared paper, 2026 · strength 0.24
  14. Andrea Viale · 1 shared paper, 2024 · strength 0.16
  15. Francesca Citron · 1 shared paper, 2024 · strength 0.16
  16. Alice Cortesi · 1 shared paper, 2024 · strength 0.16
  17. I-Lin Ho · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.